Oral Covid treatment yields promising trial data, drug makers say

German pharmaceutical giant Merck

German pharmaceutical giant Merck and a US partner reported promising results Saturday in trials of a drug administered orally to fight Covid-19, saying it helps reduce patients' viral load. 

Photo credit: Tom Mihalek | AFP

San Francisco

Welcome!

You're all set to enjoy unlimited Prime content.